** Shares of Imricor Medical Systems IMR.AX rise 4.5% to A$1.525
** Stock rose as much as 7.2% to A$1.565 earlier in the day, its largest intraday pct gain since February 14
** The medical device developer narrows FY24 adjusted net loss to $15.6 million vs $16.7 million last year
** Also logs revenue $959,424 for fiscal 2024, up from $615,568 last year
** Says revenue growth driven by capital sales and new site activations
** More than 258,000 shares change hands vs 30-day avg volume of 236,000 shares
** Stock up 13.2% YTD, including current session's moves
(Reporting by Nikita Maria Jino in Bengaluru)
((Nikita.Jino@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。